Blog > Investment Strategies > A day in the sun for two stem cell researchers: StemCells Inc. (STEM) and Brainstorm Cell Therapeutics (BCLI)
Share this article:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • NewsVine
  • StumbleUpon
  • Twitter

A day in the sun for two stem cell researchers: StemCells Inc. (STEM) and Brainstorm Cell Therapeutics (BCLI)

Today's Financial News - Posted November 10, 2008

by Laura Cadden, TodaysFinancialNews.com

Baltimore, MD (TFN): Just last week, I pondered the potential advantages in store for biotechs that could benefit from federally financed embryonic stem cell research. Read the article, "New administration could mean advances — and profits — for U.S. stem cell biotech companies" here.

Sure enough, two of the stocks I mentioned, StemCells Inc. (NASDAQ:STEM) and Brainstorm Cell Therapeutics (OTC:BCLI) are seeing gains of over 20% just today!

We are continuing to watch developments in this sector and working on a report evaluating each and every publicly-traded biotech involved in stem cell research that we can find. To be sure to be among the first to read it, just sign up for our free TFN eNews daily email…


Next Article: Will the Chinese stimulus make you money?

Related Articles

Posted by Laura Cadden · Filed Under Investment Strategies 

Share this article:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • NewsVine
  • StumbleUpon
  • Twitter

 Add to Technorati Favorites | Follow Us on Twitter!

Be the first to leave a reply.

Your comments are welcome